Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.3100
-0.0278 (-8.23%)
Oct 12, 2026, 10:47 AM EDT - Market open
Sunshine Biopharma Revenue
Sunshine Biopharma had revenue of $9.26M in the quarter ending June 30, 2026, a decrease of -1.56%. This brings the company's revenue in the last twelve months to $35.35M, down -2.74% year-over-year. In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth. That makes Sunshine Biopharma the 30,310th largest company in the world by revenue and 4,025th in the United States.
Revenue (ttm)
$35.35M
Revenue Growth
-2.74%
P/S Ratio
0.04
Revenue / Employee
$706,935
Employees
50
Market Cap
1.20M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.31M | 1.43M | 4.11% |
| Dec 31, 2024 | 34.87M | 10.78M | 44.75% |
| Dec 31, 2023 | 24.09M | 19.75M | 454.42% |
| Dec 31, 2022 | 4.35M | 4.12M | 1,802.41% |
| Dec 31, 2021 | 228.43K | 157.02K | 219.88% |
| Dec 31, 2020 | 71.41K | 50.29K | 238.10% |
| Dec 31, 2019 | 21.12K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 1.71K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Jul 31, 2009 | - | - | - |
| Jul 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IM Cannabis | 32.25M |
| Sonoma Pharmaceuticals | 21.92M |
| cbdMD | 20.93M |
| InMed Pharmaceuticals | 4.94M |
| China SXT Pharmaceuticals | 1.14M |
| Akanda | 662.47K |
| Gelteq | 314.70K |
| RedHill Biopharma | 286.00K |
SBFM News
- 2 days ago - Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering - Accesswire
- 4 days ago - Sunshine Biopharma prices $6.0M public offering - TheFly
- 4 days ago - Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering - Accesswire
- 9 days ago - Sunshine Biopharma files to sell 10.18M common units - TheFly
- 18 days ago - Sunshine Biopharma launches generic Zofran in Canada - TheFly
- 18 days ago - Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Accesswire
- 26 days ago - Sunshine Biopharma advances lead Coronavirus drug candidate - TheFly
- 26 days ago - Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Accesswire